Results 241 to 250 of about 119,819 (305)

Personalized Treatment of Patients With Multiple Sclerosis: A Case Report and Literature Review

Medicine Bulletin, EarlyView.
ABSTRACT Managing multiple sclerosis (MS) with a highly active disease course presents significant challenges, particularly regarding the timing of therapeutic escalation and the preservation of brain volume. We present a personalized management strategy for a 36‐year‐old male with relapsing‐remitting MS (RRMS) who experienced initial misdiagnosis ...
Fengjun Wang, Han Wang, Yu Zhang, Guoxun Zhang   +3 more
wiley   +1 more source

Neurodegeneration of the mastoid segment of the human facial nerve associated with senescence. [PDF]

Braz J Otorhinolaryngol
Rocha ILM, Lavinsky J, Macedo MB, Petry AUS, Malysz T.   +4 more
europepmc   +1 more source

Triggering multiple sclerosis: infection with Epstein-Barr virus activates multiple pre-existing autoreactive B and T cells. [PDF]

Signal Transduct Target Ther
Meinl E, Münz C.
europepmc   +1 more source

SirT2 Inhibition is Associated with Improvements in Depression-like Behavior and Memory Impairment in Olfactory Bulbectomized Mice. [PDF]

Mol Neurobiol
Takahashi K, Kurokawa K, Hiraga D, Takeda H, Tsuji M.   +4 more
europepmc   +1 more source

GLP‐1 Receptor Agonists for Obstructive Sleep Apnea: An Otolaryngologist's Prescription?

The Laryngoscope, EarlyView.
Alina Zgardau, Ryan Chin Taw Cheong, Kenny Peter Pang, Brian W. Rotenberg   +3 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Myelin‐Deficient Rat: Analysis of Myelin Proteins

Journal of Neurochemistry, 1986
Abstract: Myelin basic protein (BP), proteolipid protein (PLP), myelin‐associated glycoprotein (MAG), and 2′,3′‐cyclic nucleotide 3′‐phosphodiesterase (CNPase) activity were quantitated in the brains and spinal cords of normal and myelin‐deficient (md) rats at 8, 12, 18, and 25 days of age.
K, Yanagisawa, I D, Duncan, J P, Hammang, R H, Quarles   +3 more
openaire   +2 more sources